Overview

Phase I Study to Assess the Absorption, Metabolism, and Excretion of [14C] Labeled SPN-810M

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
An Open-Label, Single-Dose, Mass-Balance Study to Assess the Absorption, Metabolism, and Excretion of Radio Labeled SPN-810M in Healthy Adult Male Volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Supernus Pharmaceuticals, Inc.